Godavari Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE362C01012
NSEID:
BSEID: 530317
View on BSE

INR

96.80

-0.28 (-0.29%)

BSENSE

Sep 02, 03:30 PM

BSE+NSE Vol: 14.43 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Makers Labs.

Veerhealth Care

Concord Drugs

Vaishali Pharma

Godavari Drugs

Tyche Industries

Sotac Pharma.

Pharmaids Pharma

Krebs Biochem

Asston Pharmaceu

Curis Lifescien.

Why is Godavari Drugs Ltd ?

Weak Long Term Fundamental Strength with a -4.19% CAGR growth in Operating Profits over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.43 times

Flat results in Jun 26

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Godavari Drugs for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Godavari Drugs

13.16%

0.25

53.67%

Sensex

-4.48%

-0.33

13.39%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.90%

EBIT Growth (5y)

-4.19%

EBIT to Interest (avg)

2.25

Debt to EBITDA (avg)

3.93

Net Debt to Equity (avg)

0.88

Sales to Capital Employed (avg)

1.96

Tax Ratio

15.79%

Dividend Payout Ratio

Pledged Shares

0.21%

Institutional Holding

2.74%

ROCE (avg)

12.90%

ROE (avg)

11.67%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.50

EV to EBIT

22.37

EV to EBITDA

16.93

EV to Capital Employed

1.27

EV to Sales

1.53

PEG Ratio

Dividend Yield

ROCE (Latest)

5.94%

ROE (Latest)

5.52%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

NET SALES(Latest six months)

At Rs 61.12 cr has Grown at 23.95%

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Godavari Drugs

Net Sales - Latest six months

At Rs 61.12 cr has Grown at 23.95%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)